Health ❯ Healthcare ❯ Clinical Trials

Phase 3 Studies

IRAKLIA Study Eli Lilly HERCULES Study TRIUMPH-1 Study ASCENT-03 Study Treatment Efficacy PROTECT Study LUNA 3 Study OASIS 3 Study ENHANCE-1 Study SMA Treatments Eli Lilly and Company Purpose 2 Study LITESPARK-022 Study Motor Function Assessment TECVAYLI® Study Termination AMPLITUDE Study Drug Approval Process DREAMM-7 Study Efficacy and Safety Icotrokinra (JNJ-2113) PALOMA-3 Study Eli Lilly Studies Sleep Apnea PROTOSTAR Study LIBERTY-CUPID Study LIBERTY-CUPID Program Weight Loss Medications

6 ARTICLES

16h ago

FDA Grants Accelerated Approval to Genglycos for Glycogen Storage Disease Type Ia

The decision allows a one‑time AAV8 gene therapy for patients eight and older subject to two years of confirmatory data plus up to ten years of long‑term monitoring.

Stories older than 24h

4 ARTICLES

2mo ago

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

3 ARTICLES

2mo ago

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

4 ARTICLES

7mo ago

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

4 ARTICLES

8mo ago

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

5 ARTICLES

8mo ago

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

6 ARTICLES

8mo ago

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

3 ARTICLES

10mo ago

FDA Clears Tremfya for Children 6 and Older With Plaque Psoriasis and Psoriatic Arthritis

4 ARTICLES

this yr.

FDA Approves Ionis’ Dawnzera to Prevent Hereditary Angioedema Attacks